Form 8-K - Current report:
SEC Accession No. 0001213900-21-035560
Filing Date
2021-07-02
Accepted
2021-07-02 16:15:07
Documents
2
Period of Report
2021-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea143656-8k_aikidopharma.htm 8-K 18957
2 AMENDMENT NO. 3 TO THE EMPLOYMENT AGREEMENT WITH ANTHONY HAYES, DATED JUNE 28, 2 ea143656ex10-1_aikido.htm EX-10.1 54953
  Complete submission text file 0001213900-21-035560.txt   75420
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

EIN.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 211070222
SIC: 8731 Services-Commercial Physical & Biological Research